D-Penicillamine: Biochemical, Metabolic and Pharmacological Aspects

References

• Aarden L. A., Lakmaker F., de Groot E. Immunology of DNA. VI. The effects of mercaptans on IgG and IgM anti‐ds‐DNA. J Immunol Methods 1977; 16: 143–148
   PubMed Web of Science ®Google Scholar
• Aposhian H. V., Bradham L. S. Metabolism in vitro of the sulphydryl aminoacids, L‐ and D‐penicillamine. Biochem Pharmacology 1959; 3: 38–47
   PubMed Web of Science ®Google Scholar
• Babior B. M., Curnutte J. T., Kipnes R. S. Biological defense mechanisms. Evidence for the participation of superoxide in bacterial killing by xanthine oxidase. J Lab Clin Med 1975; 85: 235–244
   PubMed Web of Science ®Google Scholar
• Birker P. J. N. W. L., Freeman H. C. Structure, properties and function of a copper (II) complex of D‐penicillamine: Pentathallium (I)‐chlorododeca‐D (penicillaminato) octacuprate (I) hexacuprate (II)‐n‐hydrate. J Am Chem Soc 1977; 99: 6890–6900
   PubMed Web of Science ®Google Scholar
• Czekalowski J. W., Frazer J., Hall D. A. A preliminary report on the effects of D‐penicillamine and gold on certain proteolytic enzyme systems. Proc Royal Soc Med 1977; 70(Suppl. 3)126–129
   PubMedGoogle Scholar
• Ekberg M., Jeppsson J. O. Penicillamine treatment of cystinuria. Acta Med Scand 1974; 195: 415–419
   PubMedGoogle Scholar
• Eldjarn L., Hambraeus L. The rationale of mixed disulphides in the treatment of cystinuria. Scand J Clin Lab Invest 1964; 16: 153–159
   PubMed Web of Science ®Google Scholar
• Friedman M. Chemical basis for pharmacological and therapeutical actions of penicillamine. Protein Crosslinking, M. Friedman. Adv. Exp. Med., Plenum, New York 1977; vol. 86B: 649–674
   Google Scholar
• Jaffe I. A. Penicillamine treatment of rheumatoid arthritis: effect on immune complexes. Ann NY Acad Sci 1975; 256: 330–337
   PubMed Web of Science ®Google Scholar
• Jaffe I. A. Penicillamine treatment of rheumatoid arthritis. Penicillamine Research in Rheumatoid Disease, E. Munthe. Fabritius and Sønner, Oslo 1976; 11
   Google Scholar
• Jayson M. I. V., Black C. M., Lovell C. R., Bailey A. J. The effects of D‐penicillamine on collagen in systemic sclerosis and rheumatoid arthritis. Penicillamine Research in Rheumatoid Disease, E. Munthe. Fabritius and Sønner, Oslo 1976; 105
   Google Scholar
• Jellum E., Skrede S. Biological aspects of thioldisulphide reactions during treatment with penicillamine. Penicillamine Research in Rheumatoid Disease, E. Munthe. Fabritius and Sønner, Oslo 1976; 68–79
   Google Scholar
• Lengfelder E., Elstner E. F. Determination of the superoxide dismutase activity of D‐penicillamine copper. Hoppe‐Seyler's Z Physiol Chem 1978; 359: 751–757
   PubMedGoogle Scholar
• Lipsky P. E., Ziff M. Inhibition of human lymfocyte proliferation by D‐penicillamine : The role of copper complexes. XIV Intern. Congr. Rheum., San Francisco, abstr. 277. 1977
   Google Scholar
• MacGregor J. T., Clarkson T. W. Protein‐metal interactions, M. Friedman. Plenum, New York 1974; 463–503
   Google Scholar
• McCord J. M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 1974; 185: 529–531
   PubMed Web of Science ®Google Scholar
• Menander‐Huber K. B., Huber W. Orgotein, the drug version of bovine Cu/Zn superoxide dismutase. II. A summary account of clinical trials in man and animals. Superoxide and Superoxide Dismutase, A. M. Michelson, J. M. McCord, I. Fridovich. Academic Press, New York 1977; 537
   Google Scholar
• Multi‐centre trial group. Controlled trial of D‐penicillamine in severe rheumatoid arthritis. Lancet 1973; 1: 275–280
   PubMed Web of Science ®Google Scholar
• Munthe E. Penicillamine Research in Rheumatoid Disease. Fabritius and Sønner, Oslo 1976
   Google Scholar
• Nimni M. E. Molecular structure and function of collagen in normal and diseased tissues. Dynamics of Connective Tissue Macromolecules, P. M. C. Burleigh, A. R. Poole. North Holland Publishing Co., Amsterdam 1975; 51–79
   Google Scholar
• Nimni M. E. Mechanism of inhibition of collagen crosslinking by D‐penicillamine. Proc Royal Soc Med 1977; 70(Suppl. 3)65–72
   PubMedGoogle Scholar
• Patzschke K., Wegner L., Kaller H., Horsten F. A. Pharmacokinetische Untersuchungen nach oraler Applikation von radioaktiv markiertem D‐Penicillamin an Probanden. Z Rheumatoid 1977; 36: 96–105
   PubMedGoogle Scholar
• Penicillamine at 21: its place in therapeutics now. Proc Royal Soc Med 1977; 70(Suppl. 3)
   Google Scholar
• Perrett D., Sneddon W., Stephens A. D. Studies on c‐penicillamine metabolism in cystinuria and rheumatoid arthritis: isolation of S‐methyl‐D‐penicillamine. Biochem Pharmacology 1976; 25: 259–264
   PubMed Web of Science ®Google Scholar
• Perrett D. An outline of D‐penicillamine metabolism. Proc Royal Soc Med 1977; 70(Suppl. 3)61
   PubMedGoogle Scholar
• Raab W., Gemeiner B., Muckenhuber P. D Penicillamine and enzymatic activities. Enzyme 1978; 23: 84–88
   PubMedGoogle Scholar
• Saetre R., Rabenstein D. L. Determination of penicillamine in blood and urine by high performance liquid chromatography. Anal Chem 1978; 50: 276–280
   Web of Science ®Google Scholar
• Siegel R. C. Collagen crosslinking. Effect of D penicillamine on crosslinking in vitro. J Biol Chem 1977; 252: 254–259
   PubMed Web of Science ®Google Scholar
• Sorenson J. R. J. Copper chelates as possible active forms of the antiarthritic agents. J Med Chem 1976; 19: 136–148
   Web of Science ®Google Scholar
• Walshe J. M. Copper chelation in patients with Wilson's disease. Quart J Med New Series 1973; 42: 441–452
   PubMedGoogle Scholar
• Weening R. S., Wever R., Roos D. Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med 1975; 85: 245–252
   PubMed Web of Science ®Google Scholar
• Wollheim F. A., Jappsson J. O., Laurell C. B. Plasma α1‐antitrypsin‐IgA complexes, plasma cystine and urinary cysteine penicillamine disulphide excretion. Penicillamine Research in Rheumatoid Disease, E. Munthe. Fabritius and Sønner, Oslo 1976; 152
   Google Scholar
• Younes M., Weser U. Superoxide dismutase activity of copper‐penicillamine: possible involvement of Cu (I) stabilized sulphur radical. Biochem Biophys Res Commun 1977; 78: 1247–1253
   PubMed Web of Science ®Google Scholar
• Younes M., Lengfelder E., Zienau S., Wester U. Pulse radiolytically generated superoxide and Cu (II)‐salicylates. Biochem Biophys Res Commun 1978; 81: 576–580
   PubMed Web of Science ®Google Scholar